Table 1 Characteristics of the 75 mRCC patients at baseline
Characteristics | |
|---|---|
Sex, n (%) | |
Male | 60 (80) |
Female | 15 (20) |
Age, years | |
Median (range) | 55 (36–85) |
Smokers (current or past), n (%) | 36 (48) |
Histology, n (%) | |
Clear cell carcinoma | 56 (74.7) |
Papillary cell carcinoma | 8 (10.7) |
Mixt cell carcinoma | 6 (8) |
Sarcomatoid cell carcinoma | 3 (4) |
Bellini carcinoma | 1 (1.3) |
Chromophobic cell carcinoma | 1 (1.3) |
Nephrectomy, n (%) | 70 (93.3) |
Fuhrman grade, n (%) | |
1 | 1 (2) |
2 | 11 (22) |
3 | 25 (50) |
4 | 13 (26) |
Missing | 25 |
Primary metastases, n (%) | 18 (31) |
Missing | 17 |
Bone metastases, n (%) | 20 (55.6) |
Missing | 39 |
Time to metastases, months | |
Median (range) | 23 (0.2-118.4) |
Missing | 35 |
ECOG-PS, n (%) | |
0 | 24 (32) |
≥ 1 | 51 (68) |
Post mTORi anti-cancer treatment | 30 (46) |
Missing | 33 |